Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0002052113-25-001559
Filing Date
2025-04-24
Accepted
2025-04-24 09:12:39
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5651
2 EXHIBIT 24: POWER OF ATTORNEY PowerOfAttorney.txt EX-24 2796
3 EXHIBIT 99: ITEM 7 Item_7.txt EX-99 745
  Complete submission text file 0002052113-25-001559.txt   11187
Mailing Address 2 MANHATTANVILLE ROAD SUITE 203 PURCHASE NY 10577
Business Address 2 MANHATTANVILLE ROAD SUITE 203 PURCHASE NY 10577 2036352002
Teladoc Health, Inc. (Subject) CIK: 0001477449 (see all company filings)

EIN.: 043705970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-89259 | Film No.: 25863898
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)

Mailing Address 50 HUDSON YARDS NEW YORK NY 10001
Business Address 50 HUDSON YARDS NEW YORK NY 10001 (212) 810-5800
BlackRock, Inc. (Filed by) CIK: 0002012383 (see all company filings)

EIN.: 991116001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)